What are the latest developments in the quality use of medicines?
We are pleased to welcome an European Qualified Person for Pharmacovigilance (QPPV) and an Australian expert to apprise us of the latest insights on medicines utilisation in the real-world. Are improvements required in the post-marketing surveillance system and can we better utilise existing data sets to enhance monitoring of risk management plans and signal detection? During this session we look at these and other key questions on the usage of medicines in the real world from both a local and EU perspective.
- Date:May 6, 2015
- Time:9:00 am